Sentences with phrase «identified by its low price»

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

This report identifies which of 38 Canadian industries are poised for success in the new trade era that is characterized by lower commodity prices, a lower - valued Canadian dollar,...

The options allowed under the USED guidance include using counts of Identified Students (either alone, or multiplied by 1.6 to approximate the number of children who would be approved for free and reduced - price lunches); counts of students from low - income families based on state or local income surveys; and Medicaid, Temporary Assistance for Needy Families (TANF) assistance, Census (where available), or composite data authorized under the ESEA statute.

The International Value Equity strategy uses fundamental research to identify a portfolio of 50 - 80 stocks believed to be undervalued by the market (and thus have a lower price than their true worth) with portfolio construction driven by a quantitative risk - scoring framework.

We have found that it is possible to identify when prices are low by precisely defining when a pullback has occurred.

However, growth identified by a high book - to - price as yielding a higher return is quite different from «growth» typically attributed to a low book - to - price as yielding a lower return.

Renegotiate better pricing for all linens and hotel amenities purchased for the hotel by vendor sourcing and identifying low - cost suppliers, and reducing overall purchasing costs by 7 % annually.